149 related articles for article (PubMed ID: 552487)
21. Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. I. Circulating antibodies for cultured melanoma cells.
Takei M; Mishima Y; Uda H
J Cutan Pathol; 1984 Apr; 11(2):107-13. PubMed ID: 6376558
[TBL] [Abstract][Full Text] [Related]
22. A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.
Das PK; van den Wijngaard RM; Wankowicz-Kalinska A; Le Poole IC
Trends Immunol; 2001 Mar; 22(3):130-6. PubMed ID: 11286727
[TBL] [Abstract][Full Text] [Related]
23. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
Seibert E; Sorg C; Happle R; Macher E
Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
[TBL] [Abstract][Full Text] [Related]
24. Vitiligo and malignant melanoma.
Fodor J; Bodrogi I
Neoplasma; 1975; 22(4):445-8. PubMed ID: 1196428
[TBL] [Abstract][Full Text] [Related]
25. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
26. Expression of vitiligo antigen on a revertant line of hamster melanoma cells.
Naughton GK; Lipkin G; Bystryn JC
J Invest Dermatol; 1984 Nov; 83(5):317-9. PubMed ID: 6386993
[TBL] [Abstract][Full Text] [Related]
27. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo.
Galbraith GM; Miller D; Emerson DL
Clin Immunol Immunopathol; 1988 Sep; 48(3):317-24. PubMed ID: 3042212
[TBL] [Abstract][Full Text] [Related]
28. Immunologic aspects of melanoma.
Carey TE
Crit Rev Clin Lab Sci; 1982; 18(2):141-82. PubMed ID: 6295700
[No Abstract] [Full Text] [Related]
29. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
Fishman P; Merimski O; Baharav E; Shoenfeld Y
Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
[TBL] [Abstract][Full Text] [Related]
31. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
Wood GW; Barth RF
J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
[No Abstract] [Full Text] [Related]
32. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections.
Colombari R; Bonetti F; Zamboni G; Scarpa A; Marino F; Tomezzoli A; Capelli P; Menestrina F; Chilosi M; Fiore-Donati L
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):17-24. PubMed ID: 3131953
[TBL] [Abstract][Full Text] [Related]
33. The properties of antibody against smooth endoplasmic reticulum of melanocytes.
Kato T; Seiji M
Tohoku J Exp Med; 1980 Apr; 130(4):311-20. PubMed ID: 6781102
[TBL] [Abstract][Full Text] [Related]
34. Melanocyte mutation in halo naevus and malignant melanoma?
Bennett C; Copeman PW
Br J Dermatol; 1979 Apr; 100(4):423-6. PubMed ID: 378250
[TBL] [Abstract][Full Text] [Related]
35. Antigens and antibodies in malignant melanoma.
Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P
Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169
[TBL] [Abstract][Full Text] [Related]
36. Cell surface antigens of melanocytes and melanoma.
Albino AP; Houghton AN
Cancer Surv; 1985; 4(1):185-211. PubMed ID: 3842314
[TBL] [Abstract][Full Text] [Related]
37. Vitiligo and malignant melanoma: a significant association?
Gregor RT
S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
[TBL] [Abstract][Full Text] [Related]
38. Analysis of hybridoma-exchange antibodies.
Lloyd KO; Albino A; Houghton A
Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
[No Abstract] [Full Text] [Related]
39. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
[TBL] [Abstract][Full Text] [Related]
40. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.
Teulings HE; Willemsen KJ; Glykofridis I; Krebbers G; Komen L; Kroon MW; Kemp EH; Wolkerstorfer A; van der Veen JP; Luiten RM; Tjin EP
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1086-96. PubMed ID: 25043574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
